Patent Assignment
Reel/Frame 063944/0323
Assignment of Assignor's Interest
Recorded: 2023-06-14
Pages: 10
Assignor
OPIANT PHARMACEUTICALS, INC.
Executed: 2023-05-25
Assignee
INDIVIOR UK LIMITED
THE CHAPLEO BUILDING, HENRY BOOT WAY, PRIORY PARK, HULL, HU4 7DY, UNITED KINGDOM
Covered Properties
(21)
Method and Intermediates for the Preparation of Derivatives of N (1-Benzhydrylazetidin-3-Yl)-N-Phenylmethylsulfonamide
Method and Intermediates for the Preparation of Derivatives of N (1-Benzhydrylazetidin-3-Yl)-N-Phenylmethylsulfonamide
Method and Intermediates for the Preparation of Derivatives of N (1-Benzhydrylazetidin-3-Yl)-N-Phenylmethylsulfonamide
Method for Preparing Azetidine Derivatives
Compositions for Drug Administration
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Nasal Drug Products and Methods of Their Use
Application:
16/131,641 →
Publication:
US 2019/0015323
Compositions, Devices and Methods for the Treatment of Alcohol Use Disorder
Application:
16/311,944 →
Publication:
US 2019/0209464
Compositions and Methods for Treating Acute Cannabinoid Overdose with a Cannabinoid Receptor Antagonist
Application:
16/704,699 →
Publication:
US 2020/0179271
Compositions, Devices, and Methods for the Treatment of Overdose and Reward-Based Disorders
Application:
16/721,872 →
Publication:
US 2020/0390691
Compositions and Methods for Treating Cannabinoid Hyperemesis Syndrome with a Cannabinoid Receptor Antagonist
Compositions and Methods for Treating Acute Cannabinoid Overdose with a Cannabinoid Receptor Antagonist
Application:
16/904,403 →
Publication:
US 2020/0397749
Compositions, Devices, and Methods for the Treatment of Opioid-Receptor-Mediated Conditions
Application:
17/024,149 →
Publication:
US 2021/0077382
Methods and Compositions for Treating Cannabinoid Overdose with a Cannabinoid Receptor Antagonist
Application:
18/046,842 →
Publication:
US 2023/0077724
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
Assignment of Assignor's Interest
May 20, 2014
From: MAGGIO, EDWARD T
To: AEGIS THERAPEUTICS , LLC
Reel/Frame 032935/0044 →
Assignment of Assignor's Interest
Apr 3, 2015
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: LIGHTLAKE THERAPEUTICS, INC.
Reel/Frame 035328/0599 →
Assignment of Assignor's Interest
Apr 22, 2016
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: LIGHTLAKE THERAPEUTICS, INC.
Reel/Frame 038357/0246 →
Change of Name
Apr 22, 2016
From: LIGHTLAKE THERAPEUTICS, INC.
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 038502/0813 →
Assignment of Assignor's Interest
Jun 15, 2016
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: OPIANT PHARMACEUTICALS
Reel/Frame 038923/0031 →
Assignment of Assignor's Interest
Jun 15, 2016
From: KEEGAN, FINTAN; BELL, ROBERT GERARD
To: ADAPT PHARMA LIMITED
Reel/Frame 038922/0928 →
Assignment of Assignor's Interest
Nov 9, 2016
From: CRYSTAL, ROGER; BRENNER WEISS, MICHAEL
To: OPIANT PHARMACEUTICALS
Reel/Frame 040273/0005 →
Assignment of Assignor's Interest
Nov 9, 2016
From: KEEGAN, FINTAN; BELL, ROBERT GERARD
To: ADAPT PHARMA LIMITED
Reel/Frame 040272/0964 →
Assignment of Assignor's Interest
Jan 26, 2017
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 041097/0286 →
Assignment of Assignor's Interest
Feb 9, 2017
From: KEEGAN, FINTAN; BELL, ROBERT GERARD
To: ADAPT PHARMA LIMITED
Reel/Frame 041219/0676 →
Assignment of Assignor's Interest
Feb 9, 2017
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: OPIANT PHARMACEUTICALS
Reel/Frame 041219/0708 →
Assignment of Assignor's Interest
May 8, 2017
From: KEEGAN, FINTAN; BELL, ROBERT GERARD
To: ADAPT PHARMA LIMITED
Reel/Frame 042281/0248 →
Assignment of Assignor's Interest
May 8, 2017
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: OPIANT PHARMACEUTICALS
Reel/Frame 042281/0347 →
Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 046880 Frame: 0981. Assignor(S) Hereby Confirms the Assignment.
Sep 17, 2018
From: CRYSTAL, ROGER; WEISS, MICHAEL BRENNER
To: OPIANT PHARMACEUTICALS
Reel/Frame 047095/0889 →
Corrective Assignment to Correct the Conveying Party Execution Date and Application Number Previously Recorded at Reel: 046880 Frame: 0819. Assignor(S) Hereby Confirms the Assignment.
Sep 17, 2018
From: KEEGAN, FINTAN; BELL, ROBERT GERARD
To: ADAPT PHARMA LIMITED
Reel/Frame 047095/0987 →
Assignment of Assignor's Interest
Oct 16, 2019
From: CRYSTAL, ROGER; AGRAWAL, ARVIND
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 050740/0107 →
Assignment of Assignor's Interest
Oct 16, 2019
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 050740/0096 →
Assignment of Assignor's Interest
Aug 6, 2020
From: CRYSTAL, ROGER; ELLISON, MARK; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 053419/0829 →
Assignment of Assignor's Interest
Aug 6, 2020
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 053419/0262 →
Security Interest
Dec 10, 2020
From: OPIANT PHARMACEUTICALS, INC.
To: PONTIFAX MEDISON FINANCE GP, L.P.
Reel/Frame 054602/0192 →
Assignment of Assignor's Interest
Jun 2, 2021
From: SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 056410/0198 →
Security Interest
Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
Assignment of Assignor's Interest
Apr 19, 2022
From: AGRAWAL, ARVIND
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 059636/0984 →
Release of Security Interest
Mar 9, 2023
From: PONTIFAX MEDISON FINANCE GP, L.P.
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 062937/0311 →